A second pathway of activation of the Torpedo acetylcholine receptor channel.
We have studied the interaction of the reversible acetylcholine esterase inhibitor (-)physostigmine (D-eserine) with the nicotinic acetylcholine receptor (nAChR) from Torpedo marmorata electric tissue by means of ligand-induced ion flux into nAChR-rich membrane vesicles and of equilibrium binding. We find that (-) physostigmine induces cation flux (and also binds to the receptor) even in the presence of saturating concentrations of antagonists of acetylcholine, such as D-tubocurarine, alpha-bungarotoxin or antibody WF6. The direct action on the acetylcholine receptor is not affected by removal of the methylcarbamate function from the drug and thus is not due to carbamylation of the receptor. Antibodies FK1 and benzoquinonium antagonize channel activation (and binding) of eserine, suggesting that the eserine binding site(s) is separate from, but adjacent to, the acetylcholine binding site at the receptor. In addition to the channel activating site(s) with an affinity of binding in the 50 microM range, there exists a further class of low-affinity (Kd approximately mM) sites from which eserine acts as a direct blocker of the acetylcholine-activated channel. Our results suggest the existence of a second pathway of activation of the nAChR channel.
Okonjo
K O
KO
Institute of Physiological Chemistry, Johannes-Gutenberg University Medical School, Mainz, Federal Republic of Germany.
Kuhlmann
J
J
Maelicke
A
A
D000818:Animals; D000911:Antibodies, Monoclonal; D001665:Binding Sites; D002038:Bungarotoxins / Q000494:pharmacology; D002219:Carbamates / Q000378:metabolism; D002412:Cations; D002462:Cell Membrane / Q000378:metabolism; D002586:Cesium / Q000378:metabolism; D004557:Electric Organ / Q000378:metabolism; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism*; D010830:Physostigmine / Q000378:metabolism / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D014101:Torpedo; D014403:Tubocurarine / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D002038:Bungarotoxins; D002219:Carbamates; D002412:Cations; D007473:Ion Channels; D000644:Quaternary Ammonium Compounds; D011978:Receptors, Nicotinic; D002586:Cesium; D010830:Physostigmine; C004991:benzoquinonium; D014403:Tubocurarine